GeneDx Holdings Corp.
Public companyAs of Nov 18, 2026, the newest executive change on record for GeneDx Holdings Corp. is the appointment of Everett Cunningham as CEO, in an SEC 8-K filed Nov 18, 2026.Updated
- Headquarters
- STAMFORD, Connecticut
- Ticker
- WGS
- CIK
- 0001818331
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEOEverett Cunningham | Nov 18, 2026 | Appointed |
Related companies
Same industry, the same state first.
- LifeStance Health Group, Inc.
Director departs: Teresa DeLuca, M.D.
- U S PHYSICAL THERAPY INC /NV
member of the Board appointed: Myra Davis
- Longduoduo Co Ltd
member of the Registrant’s Board of Directors departs: Binbin Wu
- VSEE HEALTH, INC.
member of the Board of Directors departs: Scott Metzger
- Privia Health Group, Inc.
Class III director appointed: Opella Ernest, M.D.
- Omada Health, Inc.
Executive Chairman of the Board of Directors role change: Sean Duffy
- Executive appointment
CEO appointed: Everett Cunningham
Everett Cunningham was named CEO of GeneDx Holdings Corp.. Everett Cunningham succeeds Katherine Stueland. The company reported the change in an 8-K that cites Item 5.02.
Role: CEO
Only one public record so far. We add events as soon as a new filing lands; watch GeneDx Holdings Corp. to get them in your digest.
Last verified Nov 18, 2026
Questions about GeneDx Holdings Corp.
- Who is the new CEO of GeneDx Holdings Corp.?
- Everett Cunningham was appointed CEO of GeneDx Holdings Corp., reported in an SEC 8-K filed Nov 18, 2026. It is the newest executive change on record for GeneDx Holdings Corp. as of Nov 18, 2026.The SEC 8-K filingAll leadership changes